In the ever-evolving quest for immortality, cryopreservation has emerged as a bold frontier. Tomorrow Bio, a pioneering start-up based in Germany, is at the forefront of this radical approach, offering services that promise a future revival when technology advances sufficiently. Here’s a closer look at what this means for the future of life extension.
What Is Cryopreservation?
Cryopreservation is a technique that involves cooling biological materials—such as cells, tissues, and organs—to sub-zero temperatures to halt all biological processes. This method aims to preserve the state of these materials indefinitely. The underlying hope is that, with future technological advancements, preserved bodies or organs can be revived and potentially healed of any ailments that led to their preservation.
Tomorrow Bio’s Offerings
According to recent reports by Moneycontrol News, Tomorrow Bio offers two primary cryopreservation services:
- Full Body Preservation: Approximately ₹1.8 crore
- Brain-Only Preservation: Approximately ₹67.2 lakh
The process involves cooling the body to an astonishing minus 198 degrees Celsius, a temperature at which all biological functions are effectively paused. This state is referred to as ‘biostasis,’ and the company’s vision is to create a future where individuals can choose their lifespan, independent of current limitations.
Current Status and Ambitions
To date, Tomorrow Bio has successfully cryopreserved six people and five pets. Additionally, over 650 individuals have committed to the service and are awaiting preservation. The company’s facilities are equipped to initiate the cryopreservation process immediately following a person’s death. Specially designed ambulances in major European cities transport the bodies to Tomorrow Bio’s main facility in Switzerland. The company also has standby teams in Berlin, Amsterdam, and Zurich to facilitate this complex procedure.
Co-founder Fernando Azevedo Pinheir remains optimistic about the future. He believes that during our lifetimes, we may see the successful cryopreservation and subsequent reanimation of complex organisms. This bold vision aligns with Tomorrow Bio’s mission to democratize the choice of lifespan, making it available regardless of geographical location or financial resources.
A Glimpse into the Future
The notion of reviving individuals from a state of cryopreservation may sound like science fiction, but Tomorrow Bio’s advancements represent a significant step towards this goal. While the technology to achieve revival and treatment is still in development, the company’s ambitious vision highlights a growing interest in extending human life and exploring the limits of modern science.
Conclusion
Tomorrow Bio’s cryopreservation services offer a provocative glimpse into the future of life extension. As we continue to explore the possibilities of reversing aging and preserving life, innovations like these challenge our understanding of mortality and the potential for future breakthroughs.
